Back to top

NAATP Webinar Series: Recognition and Treatment of Psychiatric Disorders in the Addiction Population

Share this on:

Presenter: Eric Michael Kaplan, M.D.
Corporate Chief Medical Officer, Lakeview Health

The coexistence of a mental illness and a Substance Use Disorder is referred to as a co-occurring disorder. The term dual diagnosis is often used to describe this condition.

Studies show that people with a mental illness are more likely to experience a Substance Use Disorder. According to SAMHSA’s 2012 National Survey on Drug Use and Health, approximately 8.4 million adults in the United States have a co-occurring disorder.

During this presentation, Dr. Kaplan will provide epidemiologic data regarding co-occurring disorders. He’ll also discuss the diagnosis of co-occurring disorders, use of psychometric tools and DSM-5 diagnostic criteria, and psychological and pharmacologic treatments.

Objectives

The audience will receive information regarding:

  • The epidemiology of co-occurring disorders. The prevalence of the different co-occurring disorders will be discussed. The genetics of the different co-occurring disorders will be discussed.  Cultural/sex/age related factors will be discussed.
  • The co-occurrence of Major Depressive Disorder and Addictions. This will include psychometric tools helpful in diagnosing Major Depressive Disorder and the DSM-5 criteria for Major Depressive Disorder.
  • The co-occurrence of Anxiety Disorders and Addictions. This will include psychometric tools helpful in diagnosing Anxiety Disorders and the DSM-5 criteria for the various Anxiety Disorders.
  • The co-occurrence of Posttraumatic Stress Disorder and Addictions. This will include psychometric tools helpful in diagnosing Posttraumatic Stress Disorder and the DSM-5 criteria for Bipolar Disorder.
  • The co-occurrence of Bipolar Disorder and Addictions. This will include psychometric tools helpful in diagnosing Bipolar Disorder and the DSM-5 criteria for Bipolar Disorder.
  • The co-occurrence of Attention Deficit Disorder and Addictions. This will include psychometric tools helpful in diagnosing Attention Deficit Disorder and the DSM-5 criteria for Attention Deficit Disorder.
  • The various psychotherapies utilized in the treatment of co-occurring disorders.
  • The various medications utilized in the treatment of co-occurring disorders.
Presenters: 
Eric Michael Kaplan, M.D. Corporate Chief Medical Officer, Lakeview Health

Eric Michael Kaplan, M.D. has 30 years of experience in psychiatry and forensic psychiatry.

Dr. Kaplan graduated from the University of Miami School of Medicine where he earned the Herman J. Selinsky Psychiatry Award for best performance in psychiatry rotation. While completing his postgraduate education at the University of South Florida, he served as Chief Resident of the Department of Psychiatry, and earned the Chairman’s Award for Scholarly and Creative Activity and the Hibbs-Bourkard Award for being the outstanding resident in psychiatry. He continues his affiliation with the University of South Florida serving the Department of Psychiatry as an associate professor.

Dr. Kaplan has held positions as Medical Director at Charter Hospital of Pasco; St. Augustine Health Care Health Maintenance Organization; Guardian Life Insurance Company; and NeuLife Neurological Rehabilitation. He is board certified by the American College of Forensic Examiners, the American Board of Forensic Medicine, and the American Board of Disability Analysts.

RSVP Required
Date & Time: 
Thursday, February 21, 2019
11:00 am to 12:00 pm
Location: 
Webinar